Aditxt (ADTX) Gains from Investment Securities (2019 - 2026)
Aditxt (ADTX) recorded quarterly Gains from Investment Securities of $11.8 million in Q1 2026, up 82492.37% quarter-over-quarter from $14288.0 in Q4 2025, and up 89874.04% on a YoY basis from N/an in Q1 2025.
Aditxt (ADTX) Gains from Investment Securities (2019 - 2026) Analysis & Trends
Aditxt's Gains from Investment Securities history runs 8 years deep, the most recent figure standing at $11.8 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 89874.04% year-over-year to $11.8 million; the TTM figure through Mar 2026 stood at $11.8 million (changed N/A YoY), while the FY2025 annual figure was $664.0, up 120.6% from the prior year.
- Gains from Investment Securities was $11.8 million for Q1 2026 at Aditxt, up from $14288.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $11.8 million in Q1 2026 to a low of -$13145.0 in Q1 2025.
- Historically, Gains from Investment Securities has averaged $1.1 million across 5 years, with a median of $14288.0 in 2025.
- The sharpest annual moves came in 2022 and 2025: Gains from Investment Securities surged 6062400.0% in 2022, then plunged 126.29% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $127281.0 in 2022, then jumped by 3865.6% to $5.0 million in 2023, then slumped by 99.99% to $301.0 in 2024, then surged by 4646.84% to $14288.0 in 2025, then surged by 82492.37% to $11.8 million in 2026.
- The last three Gains from Investment Securities figures came in at $11.8 million (Q1 2026), $14288.0 (Q4 2025), and -$162.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.80 Mn |
| Mar 31, 2026 | 11.80 Mn |
| Dec 31, 2025 | 14,288.00 |
| Dec 31, 2025 | 14,288.00 |
| Sep 30, 2025 | -162.00 |
| Sep 30, 2025 | -162.00 |
| Jun 30, 2025 | 1.00 |
| Jun 30, 2025 | 1.00 |
| Mar 31, 2025 | -13,145.00 |
| Mar 31, 2025 | -13,145.00 |
| Dec 31, 2024 | 301.00 |
| Dec 31, 2024 | 301.00 |
| Sep 30, 2024 | 74,544.00 |
| Sep 30, 2024 | 74,544.00 |
| Jun 30, 2024 | 400.00 |
| Jun 30, 2024 | 400.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 5.05 Mn |
| Dec 31, 2023 | 5.05 Mn |